Find a study
Browse recruiting studies near you — free to check, always your choice.
5 studies
Recruiting now, in plain language. Every study is watched over by an independent ethics board.
- Multiple sclerosis (MS)💵 May compensate
This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.
Testing a new brain PET scan tracer to detect inflammation in multiple sclerosis
📍 Washington University in St. Louis · St Louis, MO · Get directions →
This study involves a Positron Emission Tomography (PET) scan using a new investigational radioactive tracer, \[18F\]-FZTA, to detect inflammation in the brain. The tracer will be tested in healthy younger adults and individuals with Multiple Sclerosis.
- Multiple sclerosis (MS)💵 May compensate
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
Testing whether ozanimod is safe and works as a step-down treatment for stable multiple sclerosis
📍 University of Colorado Anschutz Medical Campus · Aurora, CO · +2 more US sites · Get directions →
A multi-center pilot study to evaluate safety and efficacy of ozanimod as de-escalation therapy in clinically stable MS patients previously treated with anti-CD20 therapy.
- Migraine / chronic headache💵 May compensate
Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine
Studying real-world results of migraine preventive medicines targeting CGRP
📍 University of Miami, Miller School of Medicine · Miami, FL · Get directions →
The goal of this observational study is to evaluate clinical differences in patients who received preventive treatment with medication targeting calcitonin gene-related peptide (CGRP) or its receptor: monoclonal antibodies (erenumab, galcanezumab, fremanezumab, eptinezumab) or gepants (rimegepant, atogepant) during a 2-year period observation phase.
- Asthma💵 May compensate
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
Testing whether an asthma medicine can help people achieve full asthma control
📍 Sir Charles Gairdner Hospital · Nedlands, Western Australia · Get directions →
This study tests whether an asthma medication called dupilumab can help people achieve complete asthma control (called "remission") when given earlier in their disease, before asthma becomes severe. Currently, most people with asthma only receive advanced treatments like biologics after their condition has worsened significantly and caused lung damage.
- Asthma💵 May compensate
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)
Studying how bacteria and other environmental factors affect asthma
📍 NIEHS Clinical Research Unit (CRU) · Research Triangle Park, NC · Get directions →
Background: \- Asthma is a serious clinical and public health problem. Researchers want to collect data to better understand how bacteria and other things in the environment can affect people's asthma.